Possible Case Report of Furosemide-Induced Psoriasis
Journal Title: Journal of Pharmaceutics & Pharmacology - Year 2015, Vol 3, Issue 2
Abstract
Purpose: After reviewing PubMed, drug-induced psoriasis has been previously reported. This case is believed to be the first furosemide-induced psoriasis reported and includes a summarization of antihypertensive-induced psoriasis on some of the previously published literature. Summary: A 32-year-old African American female with hypertension secondary to edema was noted to have developed psoriasis 3.3 years after the initiation of furosemide 20 mg orally once daily. She initially had a new-onset rash to hydrochlorothiazide 25 mg orally once daily after 1 week prior to switching to furosemide. After presenting with her psoriatic-like skin lesions all throughout her body while on furosemide for 3.3 years, dermatologic biopsy confirmed the psoriasis diagnosis. After discontinuation of furosemide and initiation of topical and oral supportive medications, the patient’s psoriasis resolved after 4 weeks. She was changed to lisinopril 10 mg orally once daily then finally switched to losartan 50 mg orally once daily with spironolactone 50 mg orally twice daily. Conclusion: Using the scale of Naranjo et al. it was determined that furosemide use was the possible cause of the patient’s psoriasis. This report can contribute to the literature by describing another druginduced psoriasis and provide a possible first case report of furosemideinduced psoriasis.
Authors and Affiliations
Jennifer Clements
Keywords
Related Articles
- EP ID EP198083
- DOI 10.13188/2327-204X.1000016
- Views 128
- Downloads 0
Eribis Peptide 94 Mimics Ischemic Preconditioning in Rats with an Acute Myocardial Infarction and has Cardioprotective Effects during Prolonged Ischemia
Objectives: Previously, we demonstrated that a novel enkephalin analogue, Eribis Peptide 94 (EP94), produces a reduction of myocardial infarct size in rats and pigs administrated during occlusion. Since a complete dose-r...
NMDA Receptor Antagonism by Phencyclidine Reduces NWASP and WAVE1 Protein Expression and Reduces Levels of Myelination Markers in the Prefrontal Cortex of Rats
N-methyl-D-aspartate (NMDA) receptor antagonism by perinatal phencyclidine (PCP) treatment leads to neuronal damage and causes long-term behavioural alterations in rodents. It is routinely used to model pathological proc...
Invitro and Invivo Inhibition of Metyraponemetabolism by Glycyrrhetinic Acid in Male Wistar Rats
Objectives: We investigated the inhibitory effect of glycyrrhetinic acid (GA), an 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, on the reductive metabolism of metyrapone (MP) in an invitro study, and the...
A Review of Community Pharmacy-Based Pharmacologic Interventions and Methods for Smoking Cessation
Background: The aim of this study was to provide an overview of the published peer-reviewed literature related to community pharmacy-based smoking cessation counseling efforts in the United States and Canada. Methods: E...
Current Medication Trends and Global Impact on Neurodegenerative Disorders
Neurodegenerative disorders are the medical condition characterized by destruction in neuronal cells, abruption of neuronal activity and distinct involvement of the functional movement. The main neuronal disorders like P...